BERGER DISEASE
Clinical trials for BERGER DISEASE explained in plain language.
Never miss a new study
Get alerted when new BERGER DISEASE trials appear
Sign up with your email to follow new studies for BERGER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New monthly shot could tame kidney disease
Disease control OngoingThis study tests a drug called atacicept in 90 adults with IgA nephropathy, a kidney disease. Participants receive the drug every four weeks to see if it lowers harmful antibodies linked to the condition. The goal is to control the disease and prevent kidney damage.
Matched conditions: BERGER DISEASE
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New drug could slow kidney damage in IgA nephropathy patients
Disease control OngoingThis phase 3 study tests a drug called atacicept in 376 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if atacicept can reduce protein in the urine and slow the loss of kidney function compared to a placebo. Participants must hav…
Matched conditions: BERGER DISEASE
Phase: PHASE3 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC